These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Clinical association of anti-golgi autoantibodies and their autoantigens. Hong HS; Chung WH; Hung SI; Chen MJ; Lee SH; Yang LC Scand J Immunol; 2004 Jan; 59(1):79-87. PubMed ID: 14723625 [TBL] [Abstract][Full Text] [Related]
10. Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies. Albrecht I; Wick C; Hallgren Å; Tjärnlund A; Nagaraju K; Andrade F; Thompson K; Coley W; Phadke A; Diaz-Gallo LM; Bottai M; Nennesmo I; Chemin K; Herrath J; Johansson K; Wikberg A; Ytterberg AJ; Zubarev RA; Danielsson O; Krystufkova O; Vencovsky J; Landegren N; Wahren-Herlenius M; Padyukov L; Kämpe O; Lundberg IE J Clin Invest; 2015 Dec; 125(12):4612-24. PubMed ID: 26551678 [TBL] [Abstract][Full Text] [Related]
15. Journey into muscular dystrophies caused by abnormal glycosylation. Muntoni F Acta Myol; 2004 Sep; 23(2):79-84. PubMed ID: 15605948 [TBL] [Abstract][Full Text] [Related]
16. Limb-girdle muscular dystrophy type 2I is not rare in Taiwan. Liang WC; Hayashi YK; Ogawa M; Wang CH; Huang WT; Nishino I; Jong YJ Neuromuscul Disord; 2013 Aug; 23(8):675-81. PubMed ID: 23800702 [TBL] [Abstract][Full Text] [Related]
17. Mutations in the human LARGE gene cause MDC1D, a novel form of congenital muscular dystrophy with severe mental retardation and abnormal glycosylation of alpha-dystroglycan. Longman C; Brockington M; Torelli S; Jimenez-Mallebrera C; Kennedy C; Khalil N; Feng L; Saran RK; Voit T; Merlini L; Sewry CA; Brown SC; Muntoni F Hum Mol Genet; 2003 Nov; 12(21):2853-61. PubMed ID: 12966029 [TBL] [Abstract][Full Text] [Related]
18. Sequential use of immunoblots for characterization of autoantibody specificities. Bartsch H; Bachmann M Methods Mol Biol; 2009; 536():293-8. PubMed ID: 19378068 [TBL] [Abstract][Full Text] [Related]
19. A new monoclonal antibody DAG-6F4 against human alpha-dystroglycan reveals reduced core protein in some, but not all, dystroglycanopathy patients. Humphrey EL; Lacey E; Le LT; Feng L; Sciandra F; Morris CR; Hewitt JE; Holt I; Brancaccio A; Barresi R; Sewry CA; Brown SC; Morris GE Neuromuscul Disord; 2015 Jan; 25(1):32-42. PubMed ID: 25387694 [TBL] [Abstract][Full Text] [Related]
20. Autologous intramuscular transplantation of engineered satellite cells induces exosome-mediated systemic expression of Fukutin-related protein and rescues disease phenotype in a murine model of limb-girdle muscular dystrophy type 2I. Frattini P; Villa C; De Santis F; Meregalli M; Belicchi M; Erratico S; Bella P; Raimondi MT; Lu Q; Torrente Y Hum Mol Genet; 2017 Oct; 26(19):3682-3698. PubMed ID: 28666318 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]